On May 8, 2025, Biofrontera Inc. was notified by Nasdaq that its stock price was below $1.00 for 33 consecutive business days, requiring compliance by November 5, 2025, to avoid delisting. The company can take steps, including a potential reverse stock split, to regain compliance.